Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
16JUN

Mpox strain mixes genes from two clades

2 min read
10:26UTC

WHO reported a recombinant mpox virus carrying genetic elements from both clade Ib and clade IIb, now found in four countries, with transmissibility still unknown.

ScienceDeveloping
Key takeaway

A recombinant mpox strain is a surveillance signal to track, not evidence of a more dangerous virus.

WHO's Disease Outbreak News 595 reported a recombinant mpox virus (MPXV) carrying genetic elements from both clade Ib and clade IIb 1. It was first found in a UK traveller in December 2025 and identified retrospectively in India from September 2025, and now spans at least four countries across three WHO regions 2. Mpox, formerly monkeypox, circulates in distinct lineages called clades; a recombinant carries DNA from two of them at once.

Recombination happens when two virus lineages co-infect a single host and swap genetic material. It is expected wherever clades circulate together, and detecting it is the reason genomic surveillance exists rather than evidence that surveillance has failed. The strain's appearance on the record is the system working: routine sequencing flagged a hybrid and traced it back through stored samples to September 2025. This is the kind of early signal WHO's R&D Blueprint pathogen-prioritisation programme exists to catch .

WHO calls it premature to draw any conclusion about transmissibility from so few cases, and reports no serious complications in the patients identified 3. A hybrid genome does not by itself imply a more dangerous virus, so this reads as a watch item rather than an alarm. Whether the recombinant spreads or sickens differently from its parent strains is a question only more sequencing can answer, and WHO says both sequencing and surveillance are being intensified 4.

Deep Analysis

In plain English

Mpox (formerly called monkeypox) is a virus that has two main family branches, called clades. Clade Ib has been driving an outbreak in central Africa with higher death rates in unvaccinated people. Clade IIb spread globally in 2022-2024, primarily through close physical contact, and is now widespread in many countries. Scientists have now found a version of the virus that appears to have mixed genetic material from both clades, a 'recombinant' strain. It was first spotted in a UK traveller in December 2025 and found retrospectively in India from September 2025. This is a watch item, not an alarm: the WHO found the recombinant strain in at least four countries across three regions, but reported no serious illness in identified patients and says it is too early to know if this strain spreads more easily than its parent versions. Sequencing (gene-reading of more samples) is being intensified to understand what, if anything, has changed.

First Reported In

Update #4 · Ebola triples, response misfires

World Health Organization· 24 May 2026
Read original
Causes and effects
This Event
Mpox strain mixes genes from two clades
Recombination is expected where clades co-circulate; this is a surveillance signal, not yet a threat.
Different Perspectives
Indian Council of Medical Research
Indian Council of Medical Research
ICMR deployed a team to Kerala within hours of the 11 June Nipah confirmation in Kozhikode, tracing roughly 100 contacts including 58 healthcare workers; three days without fresh positives suggest containment of a pathogen with no licensed vaccine and a case-fatality rate of 40 to 75 percent.
ECDC / European Union
ECDC / European Union
ECDC's Week 23 Communicable Disease Threats Report carried four simultaneous non-Ebola signals including the first peer-reviewed evidence of Dermatophilus congolensis sexual transmission, local mpox clade Ib European spread, and the Dermatophilus rapid risk assessment due 23 June. European import risk for Bundibugyo is assessed as very low.
United States (HHS / State Department)
United States (HHS / State Department)
Washington committed $270 million bilaterally to the response on 12 June while its 30-day entry ban on DRC, Uganda and South Sudan nationals, extended to green-card holders on 5 June, expired around 17 June unresolved. The CDC's R0=2.51 modelling is the sharpest analytical contribution to the response from any national agency.
World Health Organization
World Health Organization
DON607's publication on 13 June provides the 695-case international reference and attributes the treatment trial design to national leadership rather than WHO advisory consensus; the WHO co-authors the Continental Strategic Plan with Africa CDC but holds no enforcement lever over the US entry ban expiring 17 June.
Uganda Ministry of Health
Uganda Ministry of Health
Diana Atwine's ministry traced the 14-imported-case Uganda cluster using protocols rehearsed in the 2022 Sudan ebolavirus containment of 142 cases in 113 days; Uganda co-authorises the treatment trial and Bwera border lab reduces cross-border confirmation to same-day. Nineteen confirmed cases with five from onward Kampala transmission test whether the Sudan playbook transfers.
DRC Ministry of Health
DRC Ministry of Health
Kinshasa's 14 June bulletin counted 782 confirmed cases with 45.9 percent isolated, a figure DRC's health minister has linked directly to ongoing attacks on treatment facilities rather than community resistance. DRC co-leads the clinical trial now under national authority, a regulatory posture that keeps Geneva's timeline advisory, not binding.